The essential problem for Eurostar is UK Govt doesn't know what it *wants* from long distance international rail through the Channel Tunnel
The UK Government wants to minimise its costs, and doesn't want problems, but beyond that is *has no answers*
Does the UK believe in competition on the London-Paris/Brussels routes? And if so, what sort?
Is that people might fly instead competition enough? Or is on-rail competition also desirable?
Until COVID hit, Eurostar could afford to be more expensive than flights, because the time saved and better convenience meant people favoured the train
But is that the right answer?
Would it make sense to mode-maximise instead? Not least if reducing flying for climate reasons is a supposed aim (and is part of the UK's justification for HS2)
If so, UK would need to get serious about Eurostar or whatever successor company, but then what's the strategy?
It could take the older French TGV public service model, and make sure a good number of seats were available for a low price - pricing those seats to get price conscious customers off the planes. This would take Eurostar back to its 1990s roots
Or it could allow competition to drive down prices (but that would need major changes to the operation framework, and probably extra rolling stock) - but Trenitalia vs. Italo on Milan-Rome shows what's possible
Or you could even envisage a Budgetstar that ran Stratford to Marne-la-Vallee rivalling the Eurostar that ran St Pancras to Paris Nord, with the Budgetstar being something akin to OUIGO in France
Yet if the UK Government keeps its current line - just wanting the problem to go away - Eurostar is going to go to the wall, and a SNCF Thalys-style operation will emerge instead - an even more rent seeking, anti competitive monopoly operator than Eurostar is now
Other options are available, but each of them would require *action* from the UK to achieve, yet having that sort of action in the post-Brexit context looks like a long shot to me
Why, you can imagine Grant Shapps sneering in London, should we care about the cheese eating surrender monkeys taking the Eurostar, going to France to eat their brie?
The answer to that is that these people would fly instead. They're not going to not make the trip. And if the UK (and indeed hence France and Belgium too for that matter) want to get people out of planes and into trains, this issue matters.
/ends
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Let's not forget that when the EU-UK Trade and Cooperation Agreement was finally sorted on 24 Dec, it was provisionally applied - allowing the EP to do its scrutiny this spring
2/25
Provisional application was extended from the initial end of February deadline until the end of April
A fortnight ago I wanted to answer a question: would a 🇪🇺 vaccine export ban be justified?
I was somehow instinctively against any such ban, and still am
But digging into it revealed the worst of out politics, media and social media, and how badly we cope with complexity
1/22
The essence of the issue is that this is both an ideological/ethical matter, and a practical one - and the interplay between the two is complicated
No person's response to the question ban-or-not can be based either all on ethics or all on practicality
2/22
Or - putting it another way - export of a small number of vaccines might be easier to justify than export of a massive number that would slow down the exporting region's own vaccination drive
2 days ago I wrote about Janssen / Johnson & Johnson 💉, with the tentative conclusion that an 🇪🇺-based supply chain was solid enough to mean there would be no EU-US-J&J spat to mirror the EU-UK-AZ spat
OK, so next in the series of Jon looking at supply of each different COVID vaccine it's:
Novavax
This one is different to AZ, BioNTech, J&J etc., in that the EU has no APA with Novavax *yet*
Even that is somewhat confusing - Reuters reports that this is because Novavax is dragging its heels, citing production problems reuters.com/article/health…
* Very tentative conclusions on Janssen / Johnson & Johnson vaccine supply *
It looks like EU legitimately feared a UK/AstraZeneca situation with USA for J&J - that vaccine produce in NL and finished in USA would be prevented from leaving back to EU